Summary of patients included in the study
IBD | Control | |
|---|---|---|
| No. of patients (CD/UC) | 102 (49/53) | 23 |
| No. of biopsies (CD/UC) | 193 (97/96) | 43 |
| Males/females/unknown | 40/61/1 | 7/16/0 |
| Average age (S.D.) (years) | 48 (15) | 60 (10) |
| Average BMI (S.D.) (kg/m2) | 24.9 (5.0) | 24.0 (4.0) |
| No. of patients receiving therapy | ||
| Steroids | 28 | 0 |
| Azathioprine | 17 | 0 |
| Mesalazine | 29 | 0 |
| None | 29 | 19 |
| Other | 36 | 4 |
| Smokers/nonsmokers/unknown | 26/64/12 | |
| Patients in remission | 29 | |
| Inflamed/noninflamed (biopsies total) | 73/120 | |
| Inflamed/noninflamed (paired biopsies) | 53/53 | |
| Patients excluded | 0 | 0 |